Ketamine in post-stroke depression: a report of 2 cases
Adam Włodarczyk, Jakub Słupski, Joanna Szarmach, D Milewska, Wiesław Jerzy Cubała
Frontiers in Psychiatry December 4, 2025 DOI: 10.3389/fpsyt.2025.1680687 via OpenAlex
Summary
AI-generated from the abstractKetamine may be a viable treatment option for patients with treatment-resistant post-stroke depression. Further research is needed to better understand its efficacy and safety in this specific patient population.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Population | Patients with treatment-resistant post-stroke depression |
| Intervention | Ketamine |
| Topics | Ketamine |
| Keywords | Medicine Anesthesia Clinical trial Medline |
| Key finding | Ketamine may be a viable treatment option for patients with treatment-resistant post-stroke depression. |
Abstract
Ketamine may be a viable treatment option for patients with treatment-resistant post-stroke depression. Further research is warranted to better understand the efficacy and safety of ketamine in this specific patient population.